Hyaline Membrane Disease: Follow-up

References

1. [Best Evidence] Malloy MH. Impact of cesarean section on intermediate and late preterm births: United States, 2000-2003. Birth. Mar 2009;36(1):26-33. [Medline].

2. [Best Evidence] Soll R, Ozek E. Multiple versus single doses of exogenous surfactant for the prevention or treatment of neonatal respiratory distress syndrome. Cochrane Database Syst Rev. Jan 21 2009;CD000141. [Medline].

3. [Best Evidence] Lahra MM, Beeby PJ, Jeffery HE. Maternal versus fetal inflammation and respiratory distress syndrome: a 10-year hospital cohort study. Arch Dis Child Fetal Neonatal Ed. Jan 2009;94(1):F13-6. [Medline].

4. De Luca D, Baroni S, Vento G, Piastra M, Pietrini D, Romitelli F, et al. Secretory phospholipase A2 and neonatal respiratory distress: pilot study on broncho-alveolar lavage. Intensive Care Med. Oct 2008;34(10):1858-64. [Medline].

5. Cherif A, Ben jemaa W, Kacem S, Guellouze N, Jebnoun S, Khrouf N. [Preeclampsia increases the risk of hyaline membrane disease in premature infant: a retrospective controlled study]. J Gynecol Obstet Biol Reprod (Paris). Oct 2008;37(6):597-601. [Medline].

6. Ersch J, Roth-Kleiner M, Baeckert P, Bucher HU. Increasing incidence of respiratory distress in neonates. Acta Paediatr. Nov 2007;96(11):1577-81. [Medline].

7. Teksam O, Kale G. The effects of surfactant and antenatal corticosteroid treatment on the pulmonary pathology of preterm infants with respiratory distress syndrome. Pathol Res Pract. 2009;205(1):35-41. [Medline].

8. Pole JD, Mustard CA, To T, Beyene J, Allen AC. Antenatal steroid therapy for fetal lung maturation: is there an association with childhood asthma?. J Asthma. Feb 2009;46(1):47-52. [Medline].

9. Chernick V, Kendig EL. Kendig's Disorders of the Respiratory Tract in Children, 5th ed. WB Saunders;1990: 274.

10. Cleveland RH. A radiologic update on medical diseases of the newborn chest. Pediatr Radiol. 1995;25(8):631-7. [Medline].

11. Cleveland RH, Todres ID. Patterns of evolution of X-ray changes in respiratory distress syndrome. Helv Paediatr Acta. Feb 1981;36(1):43-53. [Medline].

12. Dinger J, Schwarze R, Rupprecht E. Radiological changes after therapeutic use of surfactant in infants with respiratory distress syndrome. Pediatr Radiol. Jan 1997;27(1):26-31. [Medline].

13. Gandilo SB, Tanswell AK, Mackie KW. Pulmonary vascular air embolism in hyaline membrane disease. J Can Assoc Radiol. Dec 1977;28(4):294-6. [Medline].

14. Gortner L, Wauer RR, Hammer H, et al. Early versus late surfactant treatment in preterm infants of 27 to 32 weeks'' gestational age: a multicenter controlled clinical trial. Pediatrics. Nov 1998;102(5):1153-60. [Medline].

15. Griscom NT, Wheeler WB, Sweezey NB, et al. Bronchopulmonary dysplasia: radiographic appearance in middle childhood. Radiology. Jun 1989;171(3):811-4. [Medline].

16. Helbich TH, Popow C, Dobner M, et al. New-born infants with severe hyaline membrane disease: radiological evaluation during high frequency oscillatory versus conventional ventilation. Eur J Radiol. Oct 1998;28(3):243-9. [Medline].

17. Kamper J, Schioeler HU. Chest x-ray changes in survivors of severe idiopathic respiratory distress syndrome. Ann Radiol (Paris). 20(1):95-102. [Medline].

18. Kattwinkel J, Bloom BT, Delmore P, et al. High-versus low-threshold surfactant retreatment for neonatal respiratory distress syndrome. Pediatrics. Aug 2000;106(2 Pt 1):282-8. [Medline].

19. Kirks RD, Griscom NT. Practical pediatric imaging. Diagnostic radiology of infants and children. 3rd ed. Philadelphia: Lippincott-Raven;. 1998: 693-708.

20. Slama M, André C, Huon C, et al. Radiological analysis of hyaline membrane disease after exogenous surfactant treatment. Pediatr Radiol. Jan 1999;29(1):56-60. [Medline].

21. Slovis TL, Shankaran S. Patent ductus arteriosus in hyaline membrane disease: chest radiography. AJR Am J Roentgenol. Aug 1980;135(2):307-9. [Medline].

22. Sty JR, Wells RG, Starshak RJ. Diagnostic imaging of infants and children. Vol 3. Maryland: Aspen Publisher Inc;. 1992:123-132.

23. Swischuk LE. Bubbles in hyaline membrane disease. Differentiation of three types. Radiology. Feb 1977;122(2):417-26. [Medline].

24. Swischuk LE. Imaging of The Newborn, Infants and Young Child. Vol 1. Baltimore: Williams & Wilkins;. 1989: 28-49.

25. Taylor GA, Short BL, Kriesmer P. Extracorporeal membrane oxygenation: radiographic appearance of the neonatal chest. AJR Am J Roentgenol. Jun 1986;146(6):1257-60. [Medline].

26. Truog WE, Jackson JC, Standaert TA, et al. Acute changes in vasoactive lipid mediators in experimental hyaline membrane disease. Respir Physiol. Dec 1992;90(3):363-75. [Medline].

27. Weller MH. The roentgenographic course and complications of hyaline membrane disease. Pediatr Clin North Am. May 1973;20(2):381-406. [Medline].

28. Wohlfeld GM. Hyaline membrane disease. Am J Roentgenol Radium Ther Nucl Med. Feb 1965;93:425-7. [Medline].

29. Wolfson SL, Frech R, Hewitt C, Shanklin DR. Radiographic diagnosis of hyaline membrane disease. Radiology. Aug 1969;93(2):339-43. [Medline].

Further Reading

Clinical guidelines

Antenatal corticosteroids to prevent respiratory distress syndrome.
Royal College of Obstetricians and Gynaecologists - Medical Specialty Society.  1996 Apr (revised 2004 Feb).  9 pages.  NGC:004470

Fetal lung maturity.
American College of Obstetricians and Gynecologists - Medical Specialty Society.  2008 Sep.  10 pages.  NGC:006763

Clinical trials

Antenatal Corticoid Therapy for Late Preterm Babies

Genetic Regulation of Surfactant Deficiency

Nasal Intermittent Positive Pressure Ventilation in Premature Infants


Related eMedicine topics

Respiratory Distress Syndrome

Multiple Births

Pediatrics, Respiratory Distress Syndrome

Premature Rupture of Membranes

Preterm Labor

Keywords

hyaline membrane disease, HMD, respiratory distress syndrome, RDS, infant respiratory distress syndrome, IRDS, pulmonary disease of immaturity, neonatal respiratory failure, neonatal respiratory distress syndrome, maternal diabetes, cesarean delivery without labor, fetal asphyxia, second born of twins, antenatal steroids, surfactant therapy, pulmonary surfactants, pulmonary alveoli, pulmonary atelectasis

Contributor Information and Disclosures

Author

Peter C McClure, MD, Staff Physician, Department of Radiology, San Francisco General Hospital
Disclosure: Nothing to disclose.

Coauthor(s)

Mahesh R Patel, MD, Chief, MRI, Department of Diagnostic Imaging, Santa Clara Valley Medial Center
Mahesh R Patel, MD is a member of the following medical societies: American Roentgen Ray Society, American Society of Neuroradiology, and Radiological Society of North America
Disclosure: Nothing to disclose.

Thu T Le, MD, Staff Physician, Department of Radiology, Santa Barbara Cottage Hospital
Disclosure: Nothing to disclose.

Medical Editor

Beverly P Wood, MD, PhD, Professor Emerita, Departments of Radiology and Pediatrics, Division of Medical Education, Keck School of Medicine, University of Southern California; Professor of Clinical Radiology, Loma Linda University School of Medicine
Beverly P Wood, MD, PhD is a member of the following medical societies: American Academy of Pediatrics, American Association for Women Radiologists, American College of Radiology, American Institute of Ultrasound in Medicine, American Medical Association, American Roentgen Ray Society, Association of University Radiologists, Radiological Society of North America, and Society for Pediatric Radiology
Disclosure: Nothing to disclose.

Pharmacy Editor

Bernard D Coombs, MB, ChB, PhD, Consulting Staff, Department of Specialist Rehabilitation Services, Hutt Valley District Health Board, New Zealand
Disclosure: Nothing to disclose.

Managing Editor

Kieran McHugh, MBBCh, Honorary Lecturer, The Institute of Child Health; Consultant Pediatric Radiologist, Department of Radiology, Great Ormond Street Hospital for Children, London, UK
Kieran McHugh, MBBCh is a member of the following medical societies: American Roentgen Ray Society and Royal College of Radiologists
Disclosure: Nothing to disclose.

CME Editor

Robert M Krasny, MD, Consulting Staff, Department of Radiology, Resolution Imaging Medical Corporation
Robert M Krasny, MD is a member of the following medical societies: American Roentgen Ray Society and Radiological Society of North America
Disclosure: Nothing to disclose.

Chief Editor

Eugene C Lin, MD, Consulting Radiologist, Virginia Mason Medical Center; Clinical Assistant Professor of Radiology, University of Washington School of Medicine
Eugene C Lin, MD is a member of the following medical societies: American College of Nuclear Medicine, American College of Radiology, Radiological Society of North America, and Society of Nuclear Medicine
Disclosure: Nothing to disclose.